Nippon Shinyaku Past Earnings Performance

Past criteria checks 4/6

Nippon Shinyaku has been growing earnings at an average annual rate of 13%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 6.3% per year. Nippon Shinyaku's return on equity is 11.5%, and it has net margins of 16%.

Key information

13.0%

Earnings growth rate

13.0%

EPS growth rate

Pharmaceuticals Industry Growth	6.0%
Revenue growth rate	6.3%
Return on equity	11.5%
Net Margin	16.0%
Next Earnings Update	13 Nov 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nippon Shinyaku makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:NPNK.F Revenue, expenses and earnings (JPY Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Jun 23	145,568	23,312	34,090	25,308
31 Mar 23	144,175	22,812	33,872	24,135
31 Dec 22	141,185	25,054	33,002	22,292
30 Sep 22	137,052	23,647	32,264	22,549
30 Jun 22	131,946	20,894	31,778	23,902
31 Mar 22	137,484	24,986	31,264	22,863
31 Dec 21	136,266	28,223	30,780	20,351
30 Sep 21	135,636	29,190	30,765	18,450
30 Jun 21	133,129	27,208	30,358	16,967
31 Mar 21	121,885	20,702	29,318	16,104
31 Dec 20	120,361	20,065	28,367	14,442
30 Sep 20	117,067	16,648	27,984	15,086
30 Jun 20	117,159	17,750	27,527	13,861
31 Mar 20	116,637	16,866	27,467	13,994
31 Dec 19	115,810	15,490	27,261	15,985
30 Sep 19	118,606	18,556	26,599	15,404
30 Jun 19	116,309	17,289	26,095	16,605
31 Mar 19	114,716	16,302	26,069	16,701
31 Dec 18	110,764	13,991	25,610	15,897
30 Sep 18	105,279	11,992	25,124	14,815
30 Jun 18	105,034	12,958	24,558	14,084
31 Mar 18	101,448	12,953	23,760	13,221
31 Dec 17	100,224	10,134	24,319	16,104
30 Sep 17	103,943	14,264	23,854	16,121
30 Jun 17	99,250	12,630	23,567	14,584
31 Mar 17	98,781	11,749	23,367	14,903
31 Dec 16	97,006	14,598	22,087	10,439
30 Sep 16	89,300	9,300	21,644	10,066
30 Jun 16	88,692	8,809	21,574	9,669
31 Mar 16	84,209	6,340	21,560	9,739
31 Dec 15	84,764	6,559	21,382	9,394
30 Sep 15	82,934	5,965	21,279	9,450
30 Jun 15	81,312	5,799	21,145	9,353
31 Mar 15	79,991	5,882	20,917	8,968
31 Dec 14	79,394	6,191	20,720	9,152
30 Sep 14	77,394	5,045	20,537	9,241
30 Jun 14	76,840	5,269	20,179	9,413
31 Mar 14	76,517	5,750	19,546	9,530
31 Dec 13	74,240	4,989	19,395	9,740
30 Sep 13	72,391	4,699	19,150	9,463
30 Jun 13	71,003	4,538	18,928	9,379
31 Mar 13	69,941	4,647	18,892	9,049
31 Dec 12	68,395	4,191	18,893	8,970

Quality Earnings: NPNK.F has high quality earnings.

Growing Profit Margin: NPNK.F's current net profit margins (16%) are higher than last year (15.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: NPNK.F's earnings have grown by 13% per year over the past 5 years.

Accelerating Growth: NPNK.F's earnings growth over the past year (11.6%) is below its 5-year average (13% per year).

Earnings vs Industry: NPNK.F earnings growth over the past year (11.6%) exceeded the Pharmaceuticals industry -17.3%.

Return on Equity

High ROE: NPNK.F's Return on Equity (11.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/24 11:29
End of Day Share Price	2023/07/27 00:00
Earnings	2023/06/30
Annual Earnings	2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nippon Shinyaku Co., Ltd. is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tatsuyuki Arai	BofA Global Research
Hidemaru Yamaguchi	Citigroup Global Markets Japan Inc.
Hidemaru Yamaguchi	Citigroup Inc